pembrolizumab,ipilimumab,nivolumab,atezolizumab
merck,roche,bms
['prosper,trial', 'keynote,91', 'rcc,(-irccs),(-srcc),(-urcc)', 'check,mate,914', 'key,note,564', 'immotion010', 'checkmate914']
a packed house to hear #jameslarkin discuss perioperative #kidneycancer management! highlighting populations w benefit in #keynote564 and the 3 adjuvant/periop trials to look forward to at #esmo22! #immotion010, #prosperrcc #checkmate914 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe